Impact of low dose tocilizumab on mortality rate in patients with COVID-19 related pneumonia
Ruggero Capra, Nicola De Rossi, Flavia Mattioli, Giuseppe Romanelli, Cristina Scarpazza, Maria Pia Sormani, Stefania Cossi
Topics & Concepts
MedicineTocilizumabCoronavirus disease 2019 (COVID-19)Pneumonia2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)PandemicMortality rateInternal medicineVirologyInfectious disease (medical specialty)Rheumatoid arthritisOutbreakDiseaseCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19SARS-CoV-2 and COVID-19 Research